Xiel Announces Exclusive Distribution Agreement for MVision

by | Apr 10, 2021

New Collaboration Announcement between Xiel and MVision

Xiel are excited to announce an exclusive distributor agreement with MVision for the UK and Ireland territories.

MVision are a visionary developer of AI based segmentation for radiotherapy treatment planning. Their mission is to improve patient outcomes through increased contouring accuracy, reduced variation in planning, and upskilling of staff via automation.

Not every AI based segmentation tool is built the same, and we are particularly impressed with the quality and consistency of contouring offered by MVision.

Contact us today to learn more about this exciting technology, and how it can elevate treatment planning in your department.

‘I am delighted Xiel have officially partnered with MVision, a company leading the way in AI technology and one we have followed closely for a number of years. AI is a buzz word in our sector at the moment, and we are very excited about working with MVision, to integrate their leading technology into radiotherapy departments in the UK and Ireland.’ Jack Knight, Managing Director, Xiel Ltd.